SHINE Technologies has submitted its drug master file to the FDA for a material used in precision cancer treatment.

TUE AM News: SHINE Submits Drug Master File to FDA

Media Coverage

TUE AM News: SHINE Submits Drug Master File to FDA

No items found.

WisBusiness features SHINE in "TUE AM News: SHINE submits drug master file to FDA; Free telehealth COVID-19 treatment program ending".

Read the coverage HERE

Lutetium-177 Information Sheet (EU Distribution)Ilumira Information Sheet download PDF RESOURCE HERE